AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,205 | 87,435 | 33,099 | 89,953 | 171,609 |
| Marketable Securities | 146,774 | 27,351 | 95,359 | 126,916 | 69,329 |
| Receivables | 1,254 | 17,179 | 411 | 468 | 351 |
| Other current assets | 1,248 | 274 | 428 | 1,067 | 1,697 |
| TOTAL | $195,368 | $139,408 | $134,230 | $221,702 | $247,203 |
| Non-Current Assets | |||||
| PPE Net | 3,011 | 3,761 | 4,463 | 5,597 | 4,710 |
| Investments And Advances | 471 | 402 | 378 | 397 | 356 |
| Intangibles | 57,268 | 56,158 | 52,831 | 55,160 | 0 |
| Other Non-Current Assets | 6,176 | 3,908 | 2,943 | 3,188 | 2,371 |
| TOTAL | $66,926 | $64,229 | $60,615 | $64,343 | $7,437 |
| Total Assets | $262,294 | $203,637 | $194,844 | $286,045 | $254,640 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,019 | 1,870 | 974 | 2,192 | 2,330 |
| Accrued Expenses | 13,742 | 12,350 | 9,868 | 18,311 | 11,823 |
| TOTAL | $114,542 | $15,122 | $12,031 | $21,911 | $14,952 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 96,615 | 154 | 615 | 785 | 326 |
| Other Non-Current Liabilities | 15,045 | 9,574 | 5,728 | 10,326 | 9,860 |
| TOTAL | $20,225 | $9,574 | $5,728 | $10,326 | $9,860 |
| Total Liabilities | $134,767 | $24,696 | $17,759 | $32,237 | $24,811 |
| Shareholders' Equity | |||||
| Common Shares | 2,529 | 2,327 | 1,883 | 1,963 | 1,640 |
| Retained earnings | -418,283 | -352,212 | -276,661 | -219,851 | -141,698 |
| Other shareholders' equity | -253 | -174 | -120 | -136 | -107 |
| TOTAL | $127,528 | $178,940 | $177,086 | $253,808 | $229,829 |
| Total Liabilities And Equity | $262,294 | $203,637 | $194,845 | $286,045 | $254,640 |